tr?id=&ev=PageView&noscript=
HEALTHCARE
  • All Tags

Silhouettes of a family holding hands outside.

The ‘sandwich generation’ is strained: How to save for retirement while caring for kids and aging parents

|
50 hours, that's the amount of time America's "sandwich generation" spends caring for both children and aging parents every week. Here's what you need to know.
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone. (Photo by: Jeffrey Greenberg/Education Images/Universal Images Group via Getty Images)

Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers

| | | |
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
Kyleigh Thurman inside her home in Burnet County, Texas.

Dozens of pregnant women, some bleeding or in labor, being turned away from ERs despite federal law

| | | | | | | |
Even as the Biden administration publicly warned hospitals to treat pregnant patients in emergencies, facilities continue to violate the federal law. The issue became a focus for the administration following reports of women being improperly treated in emergency rooms after the Supreme Court’s decision to overturn the constitutional right to an abortion more than two years ago.
Kyleigh Thurman at her home in Burnet County, Texas.

Dozens of pregnant women, some bleeding or in labor, being turned away from ERs despite federal law

| |
More than 100 pregnant women in medical distress who sought help from emergency rooms were turned away or negligently treated since 2022.
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee. (Photo by Kayla Bartkowski/The Boston Globe via Getty Images)

Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats

| | | |
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
BLOCKED
BLOCKED